Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Dragalin

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Statistics in Medicine|August 6, 2008
Two-stage design for dose-finding that accounts for both efficacy and safetyVladimir Dragalin, Valerii V Fedorov, Yuehui Wu
Journal of Biopharmaceutical Statistics|November 21, 2007
Adaptive designs for dose-finding studies based on sigmoid Emax modelVladimir Dragalin, Francis Hsuan, S Krishna Padmanabhan
Statistics in Medicine|March 11, 2003
Kullback-Leibler divergence for evaluating bioequivalenceVladimir Dragalin, Valerii Fedorov, Scott Patterson, et al.
Pharmaceutical Statistics|September 27, 2012
A bivariate Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritisHelene Thygesen, Vladimir Dragalin, Anne Whitehead, et al.
Journal of Biopharmaceutical Statistics|January 19, 2012
A bayesian dose-finding design adapting to efficacy and tolerability responseS Krishna Padmanabhan, Scott Berry, Vladimir Dragalin, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial ValueTom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Statistics in Medicine|January 14, 2016
Authors' response to commentsPeter Bauer, Frank Bretz, Vladimir Dragalin, et al.
Statistics in Medicine|March 18, 2015
Twenty-five years of confirmatory adaptive designs: opportunities and pitfallsPeter Bauer, Frank Bretz, Vladimir Dragalin, et al.
Pharmaceutical Statistics|December 9, 2015
Continuous event monitoring via a Bayesian predictive approachJianing Di, Daniel Wang, H Robert Brashear, et al.
Journal of Biopharmaceutical Statistics|May 27, 2006
Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working GroupPaul Gallo, Christy Chuang-Stein, Vladimir Dragalin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Statistics in Medicine|August 6, 2008
Two-stage design for dose-finding that accounts for both efficacy and safetyVladimir Dragalin, Valerii V Fedorov, Yuehui Wu
Journal of Biopharmaceutical Statistics|November 21, 2007
Adaptive designs for dose-finding studies based on sigmoid Emax modelVladimir Dragalin, Francis Hsuan, S Krishna Padmanabhan
Statistics in Medicine|March 11, 2003
Kullback-Leibler divergence for evaluating bioequivalenceVladimir Dragalin, Valerii Fedorov, Scott Patterson, et al.
Pharmaceutical Statistics|September 27, 2012
A bivariate Bayesian dose-finding procedure applied to a seamless phase I/II trial in rheumatoid arthritisHelene Thygesen, Vladimir Dragalin, Anne Whitehead, et al.
Journal of Biopharmaceutical Statistics|January 19, 2012
A bayesian dose-finding design adapting to efficacy and tolerability responseS Krishna Padmanabhan, Scott Berry, Vladimir Dragalin, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Adaptive Design Applied to Identification of the Minimum Effective Dose in Schizophrenia: Simulations of Scientific and Commercial ValueTom Parke, Vladimir Dragalin, Ibrahim Turkoz, et al.
Statistics in Medicine|January 14, 2016
Authors' response to commentsPeter Bauer, Frank Bretz, Vladimir Dragalin, et al.
Statistics in Medicine|March 18, 2015
Twenty-five years of confirmatory adaptive designs: opportunities and pitfallsPeter Bauer, Frank Bretz, Vladimir Dragalin, et al.
Pharmaceutical Statistics|December 9, 2015
Continuous event monitoring via a Bayesian predictive approachJianing Di, Daniel Wang, H Robert Brashear, et al.
Journal of Biopharmaceutical Statistics|May 27, 2006
Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working GroupPaul Gallo, Christy Chuang-Stein, Vladimir Dragalin, et al.
Pageof 3